Indefinite Delivery Contract SPE2DX15D9629

This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $499,999,999 IDC, valid through November 2026, enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare facilities and veterans' medical centers worldwide. The contract covers an extensive portfolio of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables across various product categories such as injections, tablets, creams, auto-injectors, and specialty medications.

The task orders issued under this IDC, valued between $93 and $77,090.16, demonstrate the diverse medical supply needs being fulfilled, including specialized medications like Xolair, Trikafta, Keytruda, Botox, and Nucala. These delivery orders are awarded as firm fixed-price contracts and do not utilize any set-aside designations, allowing DMS Pharmaceutical Group to leverage its status as a woman-owned small business to secure direct federal awards across multiple product categories and medical domains. The contract supports the Defense Logistics Agency's mission to provide comprehensive pharmaceutical and medical supply solutions to the Department of Defense healthcare system.